We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$84.7B
AUM Growth
+$3.15B
Cap. Flow
-$3.2B
Cap. Flow %
-3.77%
Top 10 Hldgs %
10.93%
Holding
2,264
New
35
Increased
617
Reduced
853
Closed
525

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$128M
2
DHR icon
Danaher
DHR
+$114M
3
ZBRA icon
Zebra Technologies
ZBRA
+$112M
4
AIZ icon
Assurant
AIZ
+$92.7M
5
EXC icon
Exelon
EXC
+$92.2M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.17%
3 Financials 13.51%
4 Industrials 10.72%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANAB icon
1076
AnaptysBio
ANAB
$1.59B
$2.9M ﹤0.01%
93,732
HUBB icon
1077
Hubbell
HUBB
$26.3B
$2.9M ﹤0.01%
12,350
-21,436
-63% -$5.14M
DOX icon
1078
Amdocs
DOX
$5.64B
$2.83M ﹤0.01%
31,178
-370
-1% -$31.5K
MGNX icon
1079
MacroGenics
MGNX
$254M
$2.82M ﹤0.01%
420,000
-490
-0.1% -$2.69K
ASB icon
1080
Associated Banc-Corp
ASB
$5.78B
$2.81M ﹤0.01%
121,500
-1,651
-1% -$38.1K
IVZ icon
1081
Invesco
IVZ
$13.3B
$2.8M ﹤0.01%
155,882
NFG icon
1082
National Fuel Gas
NFG
$7.67B
$2.79M ﹤0.01%
44,100
-1,069
-2% -$68.8K
BWIN
1083
Baldwin Insurance Group
BWIN
$2.67B
$2.77M ﹤0.01%
110,302
-92,495
-46% -$2.55M
EG icon
1084
Everest Group
EG
$15.4B
$2.76M ﹤0.01%
8,334
-2,576
-24% -$803K
IMKTA icon
1085
Ingles Markets
IMKTA
$1.67B
$2.75M ﹤0.01%
28,500
SPRU icon
1086
Spruce Power Holding Corp
SPRU
$39.1M
$2.74M ﹤0.01%
+372,206
New +$2.64M
AU icon
1087
AngloGold Ashanti
AU
$40.7B
$2.73M ﹤0.01%
140,498
PZZA icon
1088
Papa John's
PZZA
$997M
$2.72M ﹤0.01%
33,090
-13,280
-29% -$1.04M
MRTX
1089
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.72M ﹤0.01%
60,000
-638
-1% -$41.3K
FITB
1090
Fifth Third Bancorp
FITB
$51.7B
$2.71M ﹤0.01%
82,679
+3,303
+4% +$113K
SKT icon
1091
Tanger
SKT
$4.8B
$2.7M ﹤0.01%
150,578
+5,261
+4% +$94.5K
MDB icon
1092
MongoDB
MDB
$24.9B
$2.7M ﹤0.01%
13,709
+4,199
+44% +$747K
IWP icon
1093
iShares Russell Mid-Cap Growth ETF
IWP
$19.8B
$2.68M ﹤0.01%
+32,110
New +$2.7M
UGI icon
1094
UGI
UGI
$7.91B
$2.67M ﹤0.01%
72,074
+6,560
+10% +$237K
ALHC icon
1095
Alignment Healthcare
ALHC
$3.86B
$2.67M ﹤0.01%
226,958
-165,509
-42% -$2.01M
COGT icon
1096
Cogent Biosciences
COGT
$6.91B
$2.66M ﹤0.01%
230,000
EQH icon
1097
Equitable Holdings
EQH
$13.3B
$2.66M ﹤0.01%
92,602
+3,117
+3% +$92.3K
JEF icon
1098
Jefferies Financial Group
JEF
$13B
$2.65M ﹤0.01%
80,960
+14,318
+21% +$476K
NUE icon
1099
Nucor
NUE
$56.4B
$2.64M ﹤0.01%
20,060
-114
-0.6% -$15.5K
FCN icon
1100
FTI Consulting
FCN
$4.88B
$2.64M ﹤0.01%
16,612
-6,144
-27% -$1.03M

Similar funds

Macquarie Group's Q4 2022 Portfolio in Review

As of Q4 2022, Macquarie Group held 2,264 positions worth $84.7B, up 3.9% from $81.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group withdrew a net $3.2B in Q4 2022, closing 525 positions and reducing 853 holdings. Its most notable exit was Abiomed Inc, an estimated $124M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in iShares 0-5 Year Investment Grade Corporate Bond ETF worth $58.3M.

  • Macquarie Group's largest Q4 2022 buy was iShares 0-5 Year Investment Grade Corporate Bond ETF: 1,218,670 shares worth $58.3M.
  • Macquarie Group added most to L3Harris in Q4 2022, an estimated $128M increase.
  • Macquarie Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $189M.
  • Macquarie Group fully exited Abiomed Inc in Q4 2022, selling an estimated $124M.
  • Macquarie Group's ten largest holdings make up 11% of its $84.7B portfolio in Q4 2022.
  • Macquarie Group opened 35 new positions and closed 525 in Q4 2022.
  • Macquarie Group's portfolio value rose 3.9% quarter-over-quarter to $84.7B.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.